Maher N. Younes

1.5k total citations
21 papers, 1.1k citations indexed

About

Maher N. Younes is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Maher N. Younes has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Maher N. Younes's work include Thyroid Cancer Diagnosis and Treatment (10 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Melanoma and MAPK Pathways (3 papers). Maher N. Younes is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (10 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Melanoma and MAPK Pathways (3 papers). Maher N. Younes collaborates with scholars based in United States, Canada and China. Maher N. Younes's co-authors include Jeffrey N. Myers, Samar A. Jasser, Adel K. El‐Naggar, Yasemin D. Yazici, Seungwon Kim, B. Nebiyou Bekele, Orhan G. Yigitbasi, Bradley A. Schiff, Mahitosh Mandal and Corazon D. Bucana and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Maher N. Younes

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maher N. Younes United States	19	517	498	315	169	158	21	1.1k
Rajiv Bassi United States	19	925 1.8×	783 1.6×	226 0.7×	280 1.7×	373 2.4×	26	1.7k
Agustín Herrero Spain	12	525 1.0×	464 0.9×	783 2.5×	151 0.9×	88 0.6×	14	1.2k
Mark G. Slomiany United States	14	780 1.5×	364 0.7×	80 0.3×	251 1.5×	85 0.5×	18	1.2k
Aizhen Xiao United States	15	393 0.8×	189 0.4×	110 0.3×	253 1.5×	90 0.6×	21	773
NR Lemoine United Kingdom	7	360 0.7×	404 0.8×	117 0.4×	85 0.5×	81 0.5×	9	709
Bradley Wubbenhorst United States	14	449 0.9×	281 0.6×	81 0.3×	311 1.8×	173 1.1×	28	1.0k
Danielle Ulanet United States	12	647 1.3×	169 0.3×	106 0.3×	182 1.1×	81 0.5×	23	1.2k
Yasuyo Ohi Japan	21	314 0.6×	635 1.3×	58 0.2×	474 2.8×	177 1.1×	60	1.2k
Eva Allonca Spain	23	570 1.1×	410 0.8×	44 0.1×	269 1.6×	158 1.0×	46	1.1k
Cunha Gr United States	6	683 1.3×	778 1.6×	51 0.2×	378 2.2×	354 2.2×	10	1.5k

Countries citing papers authored by Maher N. Younes

Since Specialization

Citations

This map shows the geographic impact of Maher N. Younes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maher N. Younes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maher N. Younes more than expected).

Fields of papers citing papers by Maher N. Younes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maher N. Younes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maher N. Younes. The network helps show where Maher N. Younes may publish in the future.

Co-authorship network of co-authors of Maher N. Younes

This figure shows the co-authorship network connecting the top 25 collaborators of Maher N. Younes. A scholar is included among the top collaborators of Maher N. Younes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maher N. Younes. Maher N. Younes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schiff, Bradley A., Samar A. Jasser, Maher N. Younes, et al.. (2019). Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer. Clinical Cancer Research. 25(15). 4862–4862. 3 indexed citations

Galer, Chad E., Zhuoying Wang, Maher N. Younes, et al.. (2010). Dual inhibition of epidermal growth factor receptor and insulin‐like growth factor receptor I: Reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma. Head & Neck. 33(2). 189–198. 48 indexed citations

Roche, Joseph P., Maher N. Younes, William K. Funkhouser, & Mark C. Weissler. (2010). Branchiogenic carcinoma of a first branchial cleft cyst. Otolaryngology. 143(1). 167–167. 12 indexed citations

Zhou, Ge, Meina Zhao, S Jasser, et al.. (2008). Reciprocal negative regulation between S100A7/psoriasin and β-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Oncogene. 27(25). 3527–3538. 49 indexed citations

Kim, Seungwon, Yasemin D. Yazici, Gabriel Calzada, et al.. (2007). Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice. Molecular Cancer Therapeutics. 6(6). 1785–1792. 113 indexed citations

Younes, Maher N., Orhan G. Yigitbasi, Yasemin D. Yazici, et al.. (2007). Effects of the Integrin-Linked Kinase Inhibitor QLT0267 on Squamous Cell Carcinoma of the Head and Neck. Archives of Otolaryngology - Head and Neck Surgery. 133(1). 15–15. 32 indexed citations

Younes, Maher N., Seung Won Kim, David Fooshee, et al.. (2007). The Tyrosine Kinase Inhibitor, AZD2171, Inhibits Vascular Endothelial Growth Factor Receptor Signaling and Growth of Anaplastic Thyroid Cancer in an Orthotopic Nude Mouse Model. Clinical Cancer Research. 13(15). 4519–4527. 36 indexed citations

Oh, Seung‐Hyun, Woo‐Young Kim, Maher N. Younes, et al.. (2006). Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 12(2). 653–661. 44 indexed citations

Wang, Zhuoying, Geetika Chakravarty, Seungwon Kim, et al.. (2006). Growth-Inhibitory Effects of Human Anti-Insulin-Like Growth Factor-I Receptor Antibody (A12) in an Orthotopic Nude Mouse Model of Anaplastic Thyroid Carcinoma. Clinical Cancer Research. 12(15). 4755–4765. 34 indexed citations

10.

Mandal, Mahitosh, Maher N. Younes, Samar A. Jasser, et al.. (2006). The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck. Oral Oncology. 42(4). 430–439. 49 indexed citations

11.

Younes, Maher N., Young Wook Park, Yasemin D. Yazici, et al.. (2006). Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model. Molecular Cancer Therapeutics. 5(11). 2696–2705. 54 indexed citations

12.

Younes, Maher N., Yasemin D. Yazici, Seungwon Kim, et al.. (2006). Dual Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor Inhibition with NVP-AEE788 for the Treatment of Aggressive Follicular Thyroid Cancer. Clinical Cancer Research. 12(11). 3425–3434. 27 indexed citations

13.

Kim, Seungwon, Maher N. Younes, Yasemin D. Yazici, et al.. (2006). Cetuximab and Irinotecan Interact Synergistically to Inhibit the Growth of Orthotopic Anaplastic Thyroid Carcinoma Xenografts in Nude Mice. Clinical Cancer Research. 12(2). 600–607. 80 indexed citations

14.

Park, Young Wook, Maher N. Younes, Samar A. Jasser, et al.. (2005). AEE788, a Dual Tyrosine Kinase Receptor Inhibitor, Induces Endothelial Cell Apoptosis in Human Cutaneous Squamous Cell Carcinoma Xenografts in Nude Mice. Clinical Cancer Research. 11(5). 1963–1973. 48 indexed citations

15.

Younes, Maher N., Orhan G. Yigitbasi, Young Wook Park, et al.. (2005). Antivascular Therapy of Human Follicular Thyroid Cancer Experimental Bone Metastasis by Blockade of Epidermal Growth Factor Receptor and Vascular Growth Factor Receptor Phosphorylation. Cancer Research. 65(11). 4716–4727. 45 indexed citations

16.

Younes, Maher N., Seungwon Kim, Orhan G. Yigitbasi, et al.. (2005). Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Molecular Cancer Therapeutics. 4(8). 1146–1156. 74 indexed citations

17.

Schiff, Bradley A., Samar A. Jasser, Maher N. Younes, et al.. (2004). Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer. Clinical Cancer Research. 10(24). 8594–8602. 142 indexed citations

18.

Younes, Maher N. & Jeffrey N. Myers. (2004). Melanoma of the head and neck: current concepts in staging, diagnosis, and management. Surgical Oncology Clinics of North America. 13(1). 201–229. 26 indexed citations

19.

Yigitbasi, Orhan G., Maher N. Younes, Dao Doan, et al.. (2004). Tumor Cell and Endothelial Cell Therapy of Oral Cancer by Dual Tyrosine Kinase Receptor Blockade. Cancer Research. 64(21). 7977–7984. 67 indexed citations

20.

Holsinger, F. Christopher, Samar A. Jasser, Jayson S. Greenberg, et al.. (2003). Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancer.. PubMed. 9(8). 3183–9. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact